These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22412192)

  • 1. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
    Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
    J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
    Neerincx A; Rodriguez GM; Steimle V; Kufer TA
    J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
    Chelbi ST; Dang AT; Guarda G
    Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
    Neerincx A; Jakobshagen K; Utermöhlen O; Büning H; Steimle V; Kufer TA
    J Immunol; 2014 Sep; 193(6):3090-100. PubMed ID: 25127861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NLRC5 limits the activation of inflammatory pathways.
    Benko S; Magalhaes JG; Philpott DJ; Girardin SE
    J Immunol; 2010 Aug; 185(3):1681-91. PubMed ID: 20610642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses.
    Kuenzel S; Till A; Winkler M; Häsler R; Lipinski S; Jung S; Grötzinger J; Fickenscher H; Schreiber S; Rosenstiel P
    J Immunol; 2010 Feb; 184(4):1990-2000. PubMed ID: 20061403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions.
    Ludigs K; Jandus C; Utzschneider DT; Staehli F; Bessoles S; Dang AT; Rota G; Castro W; Zehn D; Vivier E; Held W; Romero P; Guarda G
    Nat Commun; 2016 Feb; 7():10554. PubMed ID: 26861112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.
    Yao Y; Wang Y; Chen F; Huang Y; Zhu S; Leng Q; Wang H; Shi Y; Qian Y
    Cell Res; 2012 May; 22(5):836-47. PubMed ID: 22491475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teleost T and NK cell immunity.
    Fischer U; Koppang EO; Nakanishi T
    Fish Shellfish Immunol; 2013 Aug; 35(2):197-206. PubMed ID: 23664867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
    Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
    Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC5 deficiency has a moderate impact on immunodominant CD8
    Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
    Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
    Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
    Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
    Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal skin-derived MHC class I+, MHC class II- dendritic cells stimulate MHC class I-restricted responses of unprimed CD8+ T cells.
    Elbe A; Schleischitz S; Strunk D; Stingl G
    J Immunol; 1994 Oct; 153(7):2878-89. PubMed ID: 7522244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.
    Tong Y; Cui J; Li Q; Zou J; Wang HY; Wang RF
    Cell Res; 2012 May; 22(5):822-35. PubMed ID: 22473004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.